Viewing Study NCT00517842



Ignite Creation Date: 2024-05-05 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00517842
Status: COMPLETED
Last Update Posted: 2013-09-05
First Post: 2007-08-15

Brief Title: A Triple-blinded Randomised Placebo-controlled Trial to Examine the Efficacy and Safety of ViNeuro in Patients With Parkinsons Disease
Sponsor: Hospital Authority Hong Kong
Organization: Hospital Authority Hong Kong

Study Overview

Official Title: A Triple-blinded Randomised Placebo-controlled Trial to Examine the Efficacy and Safety of ViNeuro in Patients With Parkinsons Disease
Status: COMPLETED
Status Verified Date: 2013-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigational product is a specially formulated TCM and administered in the form of a capsule

Basic pre-clinical studies have suggested that it may have good immunomodulating functions increases the activities of T-cells B-cells and NK cells enhances mitochondrial antioxidant status on various tissues including brain tissues Therefore this formulation may have special values in improving symptoms in Parkinsons disease patients

The purpose of the study is to determine the efficacy and safety of ViNeuro in patients with Parkinsons disease
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
HARECCTR0500017 None None None